# Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

> **NCT04728295** · NA · ACTIVE_NOT_RECRUITING · sponsor: **InSightec** · enrollment: 50 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DEVICE:** Exablate 4000

## Key facts

- **NCT ID:** NCT04728295
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-14
- **Primary completion:** 2024-03-28
- **Final completion:** 2028-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04728295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04728295, "Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04728295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*